Skip to main content

Advertisement

ADVERTISEMENT

Department

News Connection
12/19/2016
In an effort to combat controversy over climbing prices, and hoping to simplify a complex system, Novo Nordisk has detailed a series of steps to ensure a “positive impact on affordability for patients,” according to a recent press release.
In an effort to combat controversy over climbing prices, and hoping to simplify a complex system, Novo Nordisk has detailed a series of steps to ensure a “positive impact on affordability for patients,” according to a recent press release.
In an effort to combat...
12/19/2016
First Report Managed Care
Formulary Frontlines®
12/19/2016
The clinical and economic burden of chronic obstructive pulmonary disease is compounded by underdiagnosis and undertreatment.
The clinical and economic burden of chronic obstructive pulmonary disease is compounded by underdiagnosis and undertreatment.
The clinical and economic burden...
12/19/2016
First Report Managed Care
Managed Care Q&A
12/15/2016
In this interview with Deborah S Keller, MD, Department of Surgery,  Baylor University Medical Center, Dr Keller discusses cost-effective invasive surgery.
In this interview with Deborah S Keller, MD, Department of Surgery,  Baylor University Medical Center, Dr Keller discusses cost-effective invasive surgery.
In this interview with Deborah S...
12/15/2016
First Report Managed Care

Advertisement

Managed Care Q&A
12/09/2016
Margaret E O’Kane continues the discussion on the evolution of quality care, including challenges that have been overcome and those that remain.
Margaret E O’Kane continues the discussion on the evolution of quality care, including challenges that have been overcome and those that remain.
Margaret E O’Kane continues the...
12/09/2016
First Report Managed Care
News Connection
11/27/2016
The future of the 21st Century Cure Act, which includes funds for medical research and aims to speed up the FDA's drug approval process, is up in the air following a recent push from patient advocacy and union groups to hold the bill until...
The future of the 21st Century Cure Act, which includes funds for medical research and aims to speed up the FDA's drug approval process, is up in the air following a recent push from patient advocacy and union groups to hold the bill until...
The future of the 21st Century...
11/27/2016
First Report Managed Care
Managed Care Q&A
11/22/2016
An interview with Albert Tzeel, MD, regional medical director, Humana
An interview with Albert Tzeel, MD, regional medical director, Humana
An interview with Albert Tzeel,...
11/22/2016
First Report Managed Care

Advertisement

News Connection
11/22/2016
Treatment with the investigational biologic ibalizumab (TaiMed Biologics/Theratechnologies) appeared to safely reduce the viral loads of patients with multidrug-resistant HIV, according to late-breaking phase III trial results recently...
Treatment with the investigational biologic ibalizumab (TaiMed Biologics/Theratechnologies) appeared to safely reduce the viral loads of patients with multidrug-resistant HIV, according to late-breaking phase III trial results recently...
Treatment with the...
11/22/2016
First Report Managed Care
News Connection
11/22/2016
A pair of identically designed phase 3 trials found that Dupixent (dupilumab; Sanofi/Regeneron) improved symptoms of moderate-to-severe atopic dermatitis, including itching, anxiety and depression, and quality of life, compared with placebo.
A pair of identically designed phase 3 trials found that Dupixent (dupilumab; Sanofi/Regeneron) improved symptoms of moderate-to-severe atopic dermatitis, including itching, anxiety and depression, and quality of life, compared with placebo.
A pair of identically designed...
11/22/2016
First Report Managed Care
News Connection
11/22/2016
Women who took Lynparza (olaparib; AstraZeneca) tablets as a monotherapy for maintenance treatment of platinum-sensitive relapsed BRCA-mutated ovarian cancer showed significantly improved progression-free survival compared with women who took...
Women who took Lynparza (olaparib; AstraZeneca) tablets as a monotherapy for maintenance treatment of platinum-sensitive relapsed BRCA-mutated ovarian cancer showed significantly improved progression-free survival compared with women who took...
Women who took Lynparza...
11/22/2016
First Report Managed Care

Advertisement

News Connection
11/22/2016
A recently study suggests amyloid positron emission tomography alongside routine cognitive impairment assessment may improve physicians’ diagnosis and management of Alzheimer disease.
A recently study suggests amyloid positron emission tomography alongside routine cognitive impairment assessment may improve physicians’ diagnosis and management of Alzheimer disease.
A recently study suggests...
11/22/2016
First Report Managed Care

Advertisement